Rege Nephro Co., Ltd.
PrivateLast Round
Debt
Jul 21, 2026
Total Funding Raised
$23.61M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Rege Nephro Co., Ltd. is a biotechnology company that develops therapeutics and cell therapy for kidney, liver, and pancreas diseases using induced pluripotent stem cell (iPSC) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rege Nephro Co., Ltd. Comparables
Compare Rege Nephro Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trestle Biotherapeutics | 81% | |
| Orizuru Therapeutics, Inc. | 74% | |
| ProKidney Corp. | 70% | |
Rege Nephro Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 21, 2026 | ||||
| Series B | Oct 7, 2024 | ||||
| Debt | Nov 1, 2023 | ||||
| Series A | Jan 31, 2022 | ||||
| VC Round | Jun 4, 2020 |
Key People
Founding team and executive leadership
Rege Nephro Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Debt, Series B, Series A |
| JAFCO Group Co., Ltd. | Debt, Series B, Series A |
| TaiAn Technologies Corp. | Debt |
| Sparx Asset Management | Debt |
| 株式会社日本政策金融公庫 | Debt |
| Tohoku University Venture Partners | Series B |
| DCI Partners | Debt, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 21, 2026
$11M raised from Arcus South East Asia and others.
- Jun 18, 2026
Monthly visitors increased 57% MoM, reaching 2.6K.
Rege Nephro Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rege Nephro Co., Ltd.'s valuation, stock price, and market status.